close
MENU
Investment
4 mins to read

Bay of Plenty-based medicinal cannabis firm Eqalis raises $6m

Company predicts it will be ‘cashflow positive’ by middle of 2023.

Eqalis strategy and operations leader David Macaskill.

Local medicinal cannabis firm Eqalis Pharmaceuticals has received great support during its latest capital raise.

The company raised $6 million from existing and new investors and was now working with its shareholders to approve up to $2m in oversubscriptions.

It was the company’s sixth funding

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Nicholas Pointon Thu, 27 Oct 2022
Contact the Writer: nicholas@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Bay of Plenty-based medicinal cannabis firm Eqalis raises $6m
Investment,
96334
true